132
Views
8
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Molecular and clinical features of chronic lymphocytic leukemia with stereotyped B-cell receptors in a Ukrainian cohort

, , , , , , , , , , , , , , , & show all
Pages 822-838 | Received 29 Sep 2009, Accepted 21 Jan 2010, Published online: 16 Mar 2010

References

  • Shanafelt T\D, Geyer SM, Kay NE. Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL. Blood 2004;103:1202–1210.
  • Bomben R, Dal Bo M, Capello D, et al Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study. Blood 2007;109:2989–2998.
  • Bomben R, Dal BM, Capello D, et al Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study. Br J Haematol 2009;144:492–506.
  • Chiorazzi N, Ferrarini M. Chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol 2003;21:841–894.
  • Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005;352:804–815.
  • Fais F, Ghiotto F, Hashimoto S, et al Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998;102:1515–1525.
  • Ghia P, Stamatopoulos K, Belessi C, et al Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood 2005;105:1678–1685.
  • Hamblin TJ, Davis Z, Gardiner A, et al Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848–1854.
  • Johnson TA, Rassenti LZ, Kipps TJ. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol 1997;158:235–246.
  • Messmer BT, Albesiano E, Messmer D, et al The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation process. Blood 2004;103:3490–3495.
  • Messmer BT, Raphael BJ, Aerni SJ, et al Computational identification of CDR3 sequence archetypes among immunoglobulin sequences in chronic lymphocytic leukemia. Leuk Res 2009;33:368–76.
  • Murray F, Darzentas N, Hadzidimitriou A, et al Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 2008;111:1524–1533.
  • Rosenquist R, Lindstrom A, Holmberg D, et al V(H) gene family utilization in different B-cell lymphoma subgroups. Eur J Haematol 1999;62:123–128.
  • Stamatopoulos K, Belessi C, Hadzidimitriou A, et al Immunoglobulin light chain repertoire in chronic lymphocytic leukemia. Blood 2005;106:3575–3583.
  • Stamatopoulos K, Belessi C, Moreno C, et al Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 2007;109:259–270.
  • Stevenson FK, Caligaris-Cappio F. Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood 2004;103:4389–4395.
  • Tobin G, Thunberg U, Karlsson K, et al Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 2004;104:2879–2885.
  • Widhopf GF, Rassenti LZ, Toy TL, et al Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 2004;104:2499–2504.
  • Widhopf GF, Goldberg CJ, Toy TL, et al Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3. Blood 2008;111:3137–3144.
  • Degan M, Bomben R, Dal Bo M, et al Analysis of IgVH gene mutations in B-CLL according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical SHM machinery. Br J Haematol 2004;126:29–42.
  • Landgren O, Rapkin JS, Caporaso NE, et al Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood 2007;109:2198–2201.
  • Herve M, Xu K, Ng YS, et al Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J Clin Invest 2005;115:1636–1643.
  • Lanemo Myhrinder A, Hellqvist E, Sidorova E, et al A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood 2008;111:3838–3848.
  • Messmer BT, Albesiano E, Efremov DG, et al Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 2004;200:519–525.
  • Thorselius M, Krober A, Murray F, et al Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. Blood 2006;107:2889–2894.
  • Tobin G, Thunberg U, Johnson A, et al Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 2003;101:4952–4957.
  • Tobin G, Soderberg O, Thunberg U, et al V(H)3-21 gene usage in chronic lymphocytic leukemia–characterization of a new subgroup with distinct molecular features and poor survival. Leuk Lymphoma 2004;45:221–228.
  • Binet JL, Auquier A, Dighiero G, et al A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981;48:198–206.
  • Rai KR, Sawitsky A, Cronkite EP, et al Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219–234.
  • Cheson BD, Bennett JM, Grever M, et al National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87:4990–4997.
  • Hallek M, Cheson BD, Catovsky D, et al Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008;111:5446–5456.
  • van Dongen JJ, Langerak AW, Bruggemann M, et al Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257–2317.
  • Abramenko I, Bilous N, Chumak A, et al Chronic lymphocytic leukemia patients exposed to ionizing radiation due to the Chernobyl NPP accident–with focus on immunoglobulin heavy chain gene analysis. Leuk Res 2008;32:535–545.
  • Damle RN, Wasil T, Fais F, et al Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840–1847.
  • Kabat EA, Wu TT, Perry HM, et al Sequences of proteins of immunological interest Darby, PA: Diane Publishing Company; 1992.
  • Thompson JD, Gibson TJ, Plewniak F, et al The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997;25:4876–4882.
  • Tschumper RC, Geyer SM, Campbell ME, et al Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients. J Clin Invest 2008;118:306–315.
  • Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005;352:804–815.
  • Rossi D, Cerri M, Capello D, et al Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome. Br J Haematol 2008;142:202–215.
  • Efremov DG, Ivanovski M, Siljanovski N, et al Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia. Blood 1996;87:3869–3876.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.